3 days Down -23.46% in 4 Weeks, Here’s Why You Should You Buy the Dip in Compass Therapeutics, Inc. (CMPX)Zacks
Compass Therapeutics, Inc. (CMPX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
X